Prevalence of anaemia in non-pregnant women (aged 15-49) in Central African Republic
Central African Republic: Prevalence of anaemia in non-pregnant women (aged 15-49) was 23.4% in 2019. ▬ Flat
Prevalence of anaemia in non-pregnant women (aged 15-49) in Central African Republic, 2000–2019
Source: World Health Organization, Global Health Observatory.
Analysis
Central African Republic recorded 23.4% for prevalence of anaemia in non-pregnant women (aged 15-49) in 2019.
The figure is down 0.4% on the previous year and up 0.4% over ten years.
Over the whole period, prevalence of anaemia in non-pregnant women (aged 15-49) in Central African Republic peaked at 23.9% in 2000 and was at its lowest, 23.3%, in 2009.
That places Central African Republic 23rd out of 194 countries with data for 2019, putting it in the top quarter.
Prevalence of anaemia in non-pregnant women (aged 15-49) in Central African Republic, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 23.9% | — |
| 2001 | 23.8% | -0.4% |
| 2002 | 23.7% | -0.4% |
| 2003 | 23.6% | -0.4% |
| 2004 | 23.6% | +0.0% |
| 2005 | 23.6% | +0.0% |
| 2006 | 23.5% | -0.4% |
| 2007 | 23.4% | -0.4% |
| 2008 | 23.4% | +0.0% |
| 2009 | 23.3% | -0.4% |
| 2010 | 23.3% | +0.0% |
| 2011 | 23.4% | +0.4% |
| 2012 | 23.4% | +0.0% |
| 2013 | 23.5% | +0.4% |
| 2014 | 23.5% | +0.0% |
| 2015 | 23.6% | +0.4% |
| 2016 | 23.6% | +0.0% |
| 2017 | 23.5% | -0.4% |
| 2018 | 23.5% | +0.0% |
| 2019 | 23.4% | -0.4% |
Central African Republic compared with similar countries
- Central African Republic's 23.4% is above the median for low income countries, which is 21.9%, 1.1× the median. (25 countries reporting)
- Central African Republic's 23.4% is above the median for Sub-Saharan Africa, which is 21.4%, 1.1× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 23.6% | 23.3% | 23.9% | 10 |
| 2010s | 23.5% | 23.3% | 23.6% | 10 |
Countries ranked near Central African Republic
More gender data for Central African Republic
- Child population (UN estimates and projections) 3,048 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 2.79 % change on previous year (2030)
- Population 3,430 (2030)
- Working-age population (UN estimates and projections) 3,430 (2030)
- Population (UN estimates and projections), annual growth rate 3.5 % change on previous year (2030)
- Age population, age 00, female, interpolated 116,671 (2025)
- Age population, age 00, male, interpolated 119,287 (2025)
- Age population, age 01, female, interpolated 111,077 (2025)
- Age population, age 01, male, interpolated 113,219 (2025)
- Age population, age 02, female, interpolated 102,344 (2025)
Frequently asked questions
- What is prevalence of anaemia in non-pregnant women (aged 15-49) in Central African Republic?
- Prevalence of anaemia in non-pregnant women (aged 15-49) in Central African Republic was 23.4% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest prevalence of anaemia in non-pregnant women (aged 15-49) recorded in Central African Republic?
- The highest recorded value was 23.9% in 2000.
- What is the lowest prevalence of anaemia in non-pregnant women (aged 15-49) recorded in Central African Republic?
- The lowest recorded value was 23.3% in 2009.
- How does Central African Republic rank for prevalence of anaemia in non-pregnant women (aged 15-49)?
- Central African Republic ranks 23rd out of 194 countries with data for 2019.
- Is prevalence of anaemia in non-pregnant women (aged 15-49) rising or falling in Central African Republic?
- Over the last ten years it is up 0.4%. The long-run trend across the full record is flat.
- Where does this Central African Republic data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Prevalence of anaemia in non-pregnant women (aged 15-49) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).